MediFind
Condition

Buerger Disease

Latest Research

Latest Advance
Study
  • Condition: Diabetic Foot
  • Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • Treatment Used: Tibial Transverse Transport (TTT)
  • Number of Patients: 516
  • Published —
This study reported results on tibial transverse transport (TTT) for the treatment of diabetic foot.
Latest Advance
Study
  • Condition: Chronic Infection of Foot and Ankle with Lower Extremity Ischemic Diseases
  • Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • Treatment Used: Tibial Transverse Transport Combined with Antibiotic Embedded Bone Cement
  • Number of Patients: 28
  • Published —
This study evaluated the effectiveness of tibial transverse transport combined with the antibiotics embedded bone cement in the treatment of chronic infection of foot and ankle with lower extremity ischemic diseases.
Latest Advance
Study
  • Condition: Buerger's Disease
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Pharmacological Treatment
  • Number of Patients: 602
  • Published —
This study assessed the effectiveness of any pharmacological agent (intravenous or oral) compared with placebo or any other pharmacological agent in patients with Buerger's disease (inflammatory disease; thromboangiitis obliterans).
Latest Advance
Study
  • Condition: Thromboangiitis Obliterans (Buerger Disease)
  • Journal: Advances in skin & wound care
  • Treatment Used: Smoking Cessation, Fat Grafting, and Other Treatments
  • Number of Patients: 1
  • Published —
This case report discusses a 29-year-old smoker diagnosed with Thromboangiitis obliterans, or Buerger disease, a rare non-atherosclerotic segmental inflammatory vasculitis that generally affects young tobacco smokers, and who was treated with fifth left toe amputation, hyperbaric therapy, and lipofilling using the Coleman technique.
Latest Advance
Study
  • Condition: Thromboangiitis Obliterans (Buerger's Disease; TAO)
  • Journal: Cardiovascular and interventional radiology
  • Treatment Used: Endovascular Recanalization and Combined Antegrade-Retrograde Intervention
  • Number of Patients: 32
  • Published —
This study evaluated the technical success of the procedure and the clinical effectiveness of treatment in patients with thromboangiitis obliterans (inflammation and clotting of small arteries;TAO) (Buerger's disease) based on a change in the Rutherford classification.
Latest Advance
Study
  • Condition: Critical Limb Ischemia (CLI) in Patients with Thromboangiitis Obliterans (TAO)
  • Journal: PloS one
  • Treatment Used: Endovascular Treatment vs. Bypass Surgery
  • Number of Patients: 33
  • Published —
This study compared the clinical outcomes between endovascular treatment and inframalleolar bypass surgery for critical limb ischemia (restricted blood flow; CLI) in patients with thromboangiitis obliterans (inflammation and clotting of small arteries; TAO) and assessed the role of bypass surgery in the era of innovative endovascular treatment.
Latest Advance
Study
  • Condition: Angiitis-induced No-option Critical Limb Ischemia
  • Journal: EBioMedicine
  • Treatment Used: purified CD34+ cells versus peripheral blood mononuclear cells
  • Number of Patients: 50
  • Published —
The purpose of the study was to compare the effectiveness and uncover the advantages associated with purified CD34+ cells versus peripheral blood mononuclear cells.
Latest Advance
Study
  • Condition: Thromboangiitis Obliterans
  • Journal: Diving and hyperbaric medicine
  • Treatment Used: hyperbaric oxygen treatment
  • Number of Patients: 97
  • Published —
The purpose of the study was to investigate the effect of hyperbaric oxygen treatment in patients with thromboangiitis obliterans.
Latest Advance
Study
  • Condition: Thromboangiitis obliterans (TAO), critical limb ischemia
  • Journal: Stem cell research & therapy
  • Treatment Used: Autologous bone marrow-derived mononuclear cells (ABMMNCs)
  • Number of Patients: 59
  • Published —
This study evaluated the long-term effects of autologous bone marrow-derived mononuclear cells (ABMMNCs) in patients with critical limb ischemia due to thromboangiitis obliterans (TAO).